Vanguard Global Advisers
MIRM icon

Vanguard Global Advisers’s Mirum Pharmaceuticals MIRM Stock Holding History

Vanguard Global Advisers’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Sell
19,853
-1,483
-7% -$149K ﹤0.01% 1159
2026
Q1 		$1.97M Buy
+21,336
New +$2.01M ﹤0.01% 1205

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Global Advisers's MIRM Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Mirum Pharmaceuticals (MIRM) stake by 7% in Q2 2026, selling an estimated $149K and leaving 19,853 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1159.

Vanguard Global Advisers first reported a position in MIRM in Q1 2026 and has held it in 2 quarters since. 325 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Vanguard Global Advisers held 19,853 shares of Mirum Pharmaceuticals worth $2.32M as of Q2 2026.
  • Vanguard Global Advisers sold 1,483 Mirum Pharmaceuticals shares in Q2 2026, an estimated $149K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1159 holding.
  • Vanguard Global Advisers first reported a position in Mirum Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 325 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.